Acute Lower Respiratory Tract Infections, Bronchiolitis, Chronic Respiratory Conditions, Pneumonia, Respiratory Syncytial Virus (RSV) Infection
Conditions
Keywords
Respiratory Syncytial Virus, RSV, RSV Infection, RSV in Infants, RSV in Adults, RSV Hospitalization, RSV Epidemiology, RSV Burden, RSV Risk Factors, Retrospective Study, Observational Study, ICU Admissions, RSV Mortality, RSV Cost Analysis, RSV Complications, Asthma and RSV, Bronchiolitis, Pneumonia, Recurrent Wheezing, RSV Surveillance, RSV-Related Comorbidities
Brief summary
This study examines the impact of Respiratory Syncytial Virus (RSV) on people of all ages, from infants to the elderly. It uses hospital records collected between January 2018 and December 2024 to understand: * How often does RSV occur * Who is most at risk * The long-term and financial effects of RSV
Detailed description
This study is designed to analyze the impact of Respiratory Syncytial Virus (RSV) across different age groups. It focuses on how often RSV occurs, who is most at risk, and its long-term and financial effects. The study uses existing hospital records from SEHA facilities between January 2018 and December 2024. This is a retrospective observational study, meaning no new tests or treatments are given. Researchers look at medical records from past patients who were diagnosed with RSV. Anonymized data is collected from SEHA's Electronic Medical Records (EMR) and laboratory systems. Only patients with confirmed RSV infections are included.
Interventions
None listed
Sponsors
Abu Dhabi Health Services Company
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Patients of all ages with a confirmed diagnosis of RSV infection * Patients admitted to a SEHA hospital or healthcare facility between January 2018 and December 2024 * Patients with documented data in the SEHA electronic medical record (EMR) system
Exclusion criteria
* Patients with suspected RSV infection that is not laboratory-confirmed * Patients without sufficient data in the SEHA EMR system
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Burden of RSV Infection Across All Age Groups | January 2018 - December 2024 | Measurement of the incidence of confirmed RSV infections in patients of all ages using SEHA hospital data from January 2018 to December 2024. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Proportion of Hospital Admissions Due to RSV | January 2018 - December 2024 | Evaluation of the percentage of total hospital admissions attributed to RSV infections. |
| ICU Admission Rates for RSV-Infected Patients | January 2018 - December 2024 | Measurement of the proportion of RSV patients requiring ICU care. |
| Financial Burden of RSV Infection | January 2018 - December 2024 | Assessment of direct medical costs associated with RSV hospitalization and ICU care. |
| Identification of Risk Factors for Severe RSV Infection | January 2018 - December 2024 | Analysis of clinical, demographic, and comorbidity data to identify key risk factors associated with severe RSV infection outcomes. |
| RSV-Associated Mortality Rates | January 2018 - December 2024 | Analysis of death rates among RSV-positive patients, including 30-day mortality post-admission. |
| Long-Term Respiratory Outcomes Following RSV Infection | Up to 12 months post-infection | Evaluation of post-RSV respiratory complications such as asthma and recurrent wheezing. |
| Incidence of Recurrent Wheezing and Asthma Diagnosis Following RSV Infection | Up to 12 months post-infection | Evaluation of long-term respiratory complications, specifically: 1. Clinically diagnosed asthma using standardized clinical criteria (e.g., based on ICD-10 codes or physician diagnosis recorded in medical records) 2. Recurrent wheezing episodes, defined as ≥3 wheezing episodes confirmed by clinical examination or parent report within 12 months post-infection, assessed via structured caregiver questionnaires and medical record review. |
Countries
United Arab Emirates
Contacts
Primary ContactLina Khairy, MD
Backup ContactAlina Naeem, MBBS, MS
Outcome results
None listed